Cresanto Global Names New Secretary, Plans Maharashtra Office Move, Name Change

Cresanto Global Limited has appointed Mrs. Pooja Abhijit Mandave as its new Company Secretary and Compliance Officer, effective April 28, 2026. The board also approved shifting the company's registered office from Uttar Pradesh to Maharashtra, amending its Memorandum of Association, and a potential name change. Shareholder approval via postal ballot is required for these significant corporate actions.

Key Appointments and Board Decisions

Cresanto Global Limited has initiated key administrative changes. Mrs. Pooja Abhijit Mandave has been appointed as the new Company Secretary and Compliance Officer, with her tenure beginning April 28, 2026.

The company's Board of Directors has also approved shifting the registered office from Uttar Pradesh to Maharashtra. This relocation requires an amendment to the company's Memorandum of Association (MoA).

Additionally, the board noted a potential change in the company's name. All these proposed changes are subject to member approval through a postal ballot.

Strategic Rationale Behind Changes

These decisions signal Cresanto Global's strategic intent to potentially centralize operations and strengthen its compliance framework. Moving the registered office to Maharashtra could improve operational efficiency, particularly if key business activities or management are located there. A name change, if approved, might indicate a new business direction or a rebranding.

The appointment of a Company Secretary is vital for statutory compliance and good corporate governance. This role became vacant following the resignation of the previous officer.

Company Background and Context

Cresanto Global Limited was formerly known as Raymed Labs Limited. Its current registered office is located in Noida, Uttar Pradesh, and the company operates in drug formulation and development. The Company Secretary and Compliance Officer role became vacant after Mr. Pankesh Sutariya resigned on February 5, 2026.

Relocating a registered office between states is a major corporate step. Companies like AstraZeneca Pharma India are currently seeking shareholder approval for a similar move from Karnataka to Maharashtra. Deep Health AI India Limited recently finalized its relocation from Maharashtra to Rajasthan. Cresanto Global has proposed name changes in the past, indicating this is not the first such initiative.

Next Steps for Cresanto Global

• Shareholders will receive a postal ballot notice to vote on the proposed office relocation, MoA amendment, and name change.
• Mrs. Pooja Abhijit Mandave will officially assume her duties as Company Secretary and Compliance Officer.
• If approved, the company will proceed with formal procedures to update its registered office address and possibly its name.
• The company must ensure compliance with all statutory requirements for the office shift and name change.

Potential Challenges and Risks

• Approval Delays: The successful relocation of the registered office and MoA amendment depend on obtaining necessary shareholder approvals via postal ballot and clearances from statutory authorities.
• Name Change Uncertainty: The proposed name change also requires member approval and might not be implemented if it lacks sufficient support.
• Execution Risk: The entire process involves complex regulatory filings and compliance, carrying potential for delays or unexpected challenges.

Industry Context and Peers

Cresanto Global operates within the healthcare and pharmaceutical sector, with a small market capitalization of approximately ₹1.99 crore as of April 20, 2026. Its comparable peers in the small-cap segment include Kobo Biotech, Gian Life Care, MPS Pharmaa, and Fabino Enterprises. While direct financial comparisons for this specific corporate action are not applicable, other companies in the sector, such as AstraZeneca Pharma India, are managing similar registered office relocation processes, reflecting common industry administrative and regulatory procedures.

Key Metrics

• The company's market capitalization was ₹1.99 Cr as of April 20, 2026.
• Promoter holding stood at 32.27% as of March 2026.

What to Watch For

• The issuance and results of the postal ballot for shareholder approval.
• Formal confirmation of shareholder consent for the office relocation, MoA amendment, and name change.
• Receipt of approvals from relevant statutory authorities for the registered office shift.
• Official announcements regarding any company name change and updated registered office details.
• Subsequent regulatory filings to finalize the transfer and name change processes.